Literature DB >> 3965703

gamma-Aminobutyric acid esters. 2. Synthesis, brain uptake, and pharmacological properties of lipid esters of gamma-aminobutyric acid.

J N Jacob, V E Shashoua, A Campbell, R J Baldessarini.   

Abstract

Two lipid esters of U-14C-labeled and unlabeled gamma-aminobutyric acid (GABA) were synthesized to test the possibility that natural lipid analogues, which resemble normal components of lipid bilayer membranes, can penetrate the blood-brain barrier and transport exogenous GABA to the brain. The uptake of 1-linolenoyl-2,3-bis(4-aminobutyryl)propane-1,2,3-triol and 1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol into mouse brain relative to liver was found to be, respectively, 75- and 127-fold greater than that of free GABA. The results indicate that there is little or no blood-brain barrier for the GABA ester molecules at doses up to 0.36 mmol/kg. Both ester compounds, but neither free GABA nor the lipid components delivered systemically, demonstrated central nervous system depressant properties by inhibiting the general motor activity of mice. Brain tissue has esterase activity which can release GABA from these compounds. This suggests that these compounds function as "prodrugs" to release GABA in the CNS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965703     DOI: 10.1021/jm00379a019

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Structure-metabolism relationships in the hydrolysis of nicotinate esters by rat liver and brain subcellular fractions.

Authors:  A Durrer; B Walther; A Racciatti; G Boss; B Testa
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

2.  Adenosine analogs with covalently attached lipids have enhanced potency at A1-adenosine receptors.

Authors:  K A Jacobson; J Zimmet; R Schulick; S Barone; J W Daly; K L Kirk
Journal:  FEBS Lett       Date:  1987-12-10       Impact factor: 4.124

3.  Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor.

Authors:  D M Lambert; F Mergen; C F Berens; J H Poupaert; P Dumont
Journal:  Pharm Res       Date:  1995-02       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.